- call +1-201-465-4211
- email sales@mrinsights.biz
Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.
Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens.
Scope of the Report:
The classification of Newcastle Disease Vaccine includes Live Vaccines and Killed Vaccines. The proportion of Killed Vaccines in 2016 is about 77.1%, These vaccines are made with virus that is alive and able to infect cells. Strains of virus of low or moderate virulence are used. They mimic natural infection and induce all three immune responses. And the proportion of Live Vaccines in 2016 is about 22.9%.
Newcastle Disease Vaccine is application in Chicken, Duck & Goose and others. The most of Newcastle Disease Vaccine is used in Chicken, and the market share in 2016 is about 87.5%.
Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans. Newcastle disease can causes devastating losses in both commercial and village chickens. So Newcastle Disease Vaccine is necessary for farms with Chicken, Duck & Goose, etc.
Market competition is intense. Merial, CEVA, QYH Biotech, Ringpu Biology, etc. are the leader of this industry. With the development of society and the changing of consumer demand, the Newcastle Disease Vaccine industry will be more and more popular in the future.
The worldwide market for Newcastle Disease Vaccine is expected to grow at a CAGR of roughly 3.6% over the next five years, will reach 340 million US$ in 2024, from 280 million US$ in 2019, according to a new study.
This report focuses on the Newcastle Disease Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Merial
CEVA
QYH Biotech
Ringpu Biology
Yebio
Harbin Veterinary Research Institute
Merck Animal Health
DHN
Zoetis
ChengDu Tecbond
Elanco (Lohmann)
FATRO
CAVAC
Vaksindo
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Live Vaccines
Killed Vaccines
Market Segment by Applications, can be divided into
Chicken
Duck & Goose
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Newcastle Disease Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Newcastle Disease Vaccine, with price, sales, revenue and global market share of Newcastle Disease Vaccine in 2017 and 2018.
Chapter 3, the Newcastle Disease Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Newcastle Disease Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Newcastle Disease Vaccine market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Newcastle Disease Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Newcastle Disease Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Live Vaccines
1.2.2 Killed Vaccines
1.3 Market Analysis by Applications
1.3.1 Chicken
1.3.2 Duck & Goose
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merial
2.1.1 Business Overview
2.1.2 Newcastle Disease Vaccine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Merial Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 CEVA
2.2.1 Business Overview
2.2.2 Newcastle Disease Vaccine Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 CEVA Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 QYH Biotech
2.3.1 Business Overview
2.3.2 Newcastle Disease Vaccine Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 QYH Biotech Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Ringpu Biology
2.4.1 Business Overview
2.4.2 Newcastle Disease Vaccine Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Ringpu Biology Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Yebio
2.5.1 Business Overview
2.5.2 Newcastle Disease Vaccine Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Yebio Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Harbin Veterinary Research Institute
2.6.1 Business Overview
2.6.2 Newcastle Disease Vaccine Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Merck Animal Health
2.7.1 Business Overview
2.7.2 Newcastle Disease Vaccine Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Merck Animal Health Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 DHN
2.8.1 Business Overview
2.8.2 Newcastle Disease Vaccine Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 DHN Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Zoetis
2.9.1 Business Overview
2.9.2 Newcastle Disease Vaccine Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Zoetis Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 ChengDu Tecbond
2.10.1 Business Overview
2.10.2 Newcastle Disease Vaccine Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 ChengDu Tecbond Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Elanco (Lohmann)
2.11.1 Business Overview
2.11.2 Newcastle Disease Vaccine Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Elanco (Lohmann) Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 FATRO
2.12.1 Business Overview
2.12.2 Newcastle Disease Vaccine Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 FATRO Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.13 CAVAC
2.13.1 Business Overview
2.13.2 Newcastle Disease Vaccine Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 CAVAC Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.14 Vaksindo
2.14.1 Business Overview
2.14.2 Newcastle Disease Vaccine Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Vaksindo Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Newcastle Disease Vaccine Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Newcastle Disease Vaccine Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Newcastle Disease Vaccine Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Newcastle Disease Vaccine Manufacturer Market Share in 2018
3.3.2 Top 6 Newcastle Disease Vaccine Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Newcastle Disease Vaccine Market Analysis by Regions
4.1 Global Newcastle Disease Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Newcastle Disease Vaccine Sales and Market Share by Regions (2014-2019)
4.1.2 Global Newcastle Disease Vaccine Revenue and Market Share by Regions (2014-2019)
4.2 North America Newcastle Disease Vaccine Sales and Growth Rate (2014-2019)
4.3 Europe Newcastle Disease Vaccine Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Newcastle Disease Vaccine Sales and Growth Rate (2014-2019)
4.5 South America Newcastle Disease Vaccine Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Newcastle Disease Vaccine Sales and Growth Rate (2014-2019)
5 North America Newcastle Disease Vaccine by Country
5.1 North America Newcastle Disease Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Newcastle Disease Vaccine Sales and Market Share by Country (2014-2019)
5.1.2 North America Newcastle Disease Vaccine Revenue and Market Share by Country (2014-2019)
5.2 United States Newcastle Disease Vaccine Sales and Growth Rate (2014-2019)
5.3 Canada Newcastle Disease Vaccine Sales and Growth Rate (2014-2019)
5.4 Mexico Newcastle Disease Vaccine Sales and Growth Rate (2014-2019)
6 Europe Newcastle Disease Vaccine by Country
6.1 Europe Newcastle Disease Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Newcastle Disease Vaccine Sales and Market Share by Country (2014-2019)
6.1.2 Europe Newcastle Disease Vaccine Revenue and Market Share by Country (2014-2019)
6.2 Germany Newcastle Disease Vaccine Sales and Growth Rate (2014-2019)
6.3 UK Newcastle Disease Vaccine Sales and Growth Rate (2014-2019)
6.4 France Newcastle Disease Vaccine Sales and Growth Rate (2014-2019)
6.5 Russia Newcastle Disease Vaccine Sales and Growth Rate (2014-2019)
6.6 Italy Newcastle Disease Vaccine Sales and Growth Rate (2014-2019)
7 Asia-Pacific Newcastle Disease Vaccine by Country
7.1 Asia-Pacific Newcastle Disease Vaccine Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Newcastle Disease Vaccine Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Newcastle Disease Vaccine Revenue and Market Share by Country (2014-2019)
7.2 China Newcastle Disease Vaccine Sales and Growth Rate (2014-2019)
7.3 Japan Newcastle Disease Vaccine Sales and Growth Rate (2014-2019)
7.4 Korea Newcastle Disease Vaccine Sales and Growth Rate (2014-2019)
7.5 India Newcastle Disease Vaccine Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Newcastle Disease Vaccine Sales and Growth Rate (2014-2019)
8 South America Newcastle Disease Vaccine by Country
8.1 South America Newcastle Disease Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Newcastle Disease Vaccine Sales and Market Share by Country (2014-2019)
8.1.2 South America Newcastle Disease Vaccine Revenue and Market Share by Country (2014-2019)
8.2 Brazil Newcastle Disease Vaccine Sales and Growth Rate (2014-2019)
8.3 Argentina Newcastle Disease Vaccine Sales and Growth Rate (2014-2019)
8.4 Colombia Newcastle Disease Vaccine Sales and Growth Rate (2014-2019)
9 Middle East and Africa Newcastle Disease Vaccine by Countries
9.1 Middle East and Africa Newcastle Disease Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Newcastle Disease Vaccine Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Newcastle Disease Vaccine Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Newcastle Disease Vaccine Sales and Growth Rate (2014-2019)
9.3 Turkey Newcastle Disease Vaccine Sales and Growth Rate (2014-2019)
9.4 Egypt Newcastle Disease Vaccine Sales and Growth Rate (2014-2019)
9.5 Nigeria Newcastle Disease Vaccine Sales and Growth Rate (2014-2019)
9.6 South Africa Newcastle Disease Vaccine Sales and Growth Rate (2014-2019)
10 Global Newcastle Disease Vaccine Market Segment by Type
10.1 Global Newcastle Disease Vaccine Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Newcastle Disease Vaccine Sales and Market Share by Type (2014-2019)
10.1.2 Global Newcastle Disease Vaccine Revenue and Market Share by Type (2014-2019)
10.2 Live Vaccines Sales Growth and Price
10.2.1 Global Live Vaccines Sales Growth (2014-2019)
10.2.2 Global Live Vaccines Price (2014-2019)
10.3 Killed Vaccines Sales Growth and Price
10.3.1 Global Killed Vaccines Sales Growth (2014-2019)
10.3.2 Global Killed Vaccines Price (2014-2019)
11 Global Newcastle Disease Vaccine Market Segment by Application
11.1 Global Newcastle Disease Vaccine Sales Market Share by Application (2014-2019)
11.2 Chicken Sales Growth (2014-2019)
11.3 Duck & Goose Sales Growth (2014-2019)
11.4 Other Sales Growth (2014-2019)
12 Newcastle Disease Vaccine Market Forecast (2019-2024)
12.1 Global Newcastle Disease Vaccine Sales, Revenue and Growth Rate (2019-2024)
12.2 Newcastle Disease Vaccine Market Forecast by Regions (2019-2024)
12.2.1 North America Newcastle Disease Vaccine Market Forecast (2019-2024)
12.2.2 Europe Newcastle Disease Vaccine Market Forecast (2019-2024)
12.2.3 Asia-Pacific Newcastle Disease Vaccine Market Forecast (2019-2024)
12.2.4 South America Newcastle Disease Vaccine Market Forecast (2019-2024)
12.2.5 Middle East and Africa Newcastle Disease Vaccine Market Forecast (2019-2024)
12.3 Newcastle Disease Vaccine Market Forecast by Type (2019-2024)
12.3.1 Global Newcastle Disease Vaccine Sales Forecast by Type (2019-2024)
12.3.2 Global Newcastle Disease Vaccine Market Share Forecast by Type (2019-2024)
12.4 Newcastle Disease Vaccine Market Forecast by Application (2019-2024)
12.4.1 Global Newcastle Disease Vaccine Sales Forecast by Application (2019-2024)
12.4.2 Global Newcastle Disease Vaccine Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Newcastle Disease Vaccine Picture
Table Product Specifications of Newcastle Disease Vaccine
Figure Global Sales Market Share of Newcastle Disease Vaccine by Types in
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
